[MAXIS] QoQ Cumulative Quarter Result on 30-Jun-2016 [#2]

Announcement Date
20-Jul-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- 94.21%
YoY- 18.21%
Quarter Report
View:
Show?
Cumulative Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 2,375,000 8,612,000 6,398,000 4,242,000 2,140,000 8,601,000 6,425,000 -48.46%
PBT 673,000 2,737,000 2,062,000 1,382,000 734,000 2,460,000 1,787,000 -47.81%
Tax -171,000 -724,000 -554,000 -379,000 -214,000 -713,000 -510,000 -51.70%
NP 502,000 2,013,000 1,508,000 1,003,000 520,000 1,747,000 1,277,000 -46.30%
-
NP to SH 502,000 2,013,000 1,509,000 1,006,000 518,000 1,739,000 1,271,000 -46.13%
-
Tax Rate 25.41% 26.45% 26.87% 27.42% 29.16% 28.98% 28.54% -
Total Cost 1,873,000 6,599,000 4,890,000 3,239,000 1,620,000 6,854,000 5,148,000 -49.00%
-
Net Worth 4,823,880 4,732,052 4,579,552 4,429,402 4,279,130 4,197,586 4,061,183 12.14%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div 376,865 1,502,238 1,126,119 750,746 375,362 1,499,137 1,128,106 -51.82%
Div Payout % 75.07% 74.63% 74.63% 74.63% 72.46% 86.21% 88.76% -
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 4,823,880 4,732,052 4,579,552 4,429,402 4,279,130 4,197,586 4,061,183 12.14%
NOSH 7,537,313 7,511,194 7,507,462 7,507,462 7,507,246 7,495,689 7,520,710 0.14%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 21.14% 23.37% 23.57% 23.64% 24.30% 20.31% 19.88% -
ROE 10.41% 42.54% 32.95% 22.71% 12.11% 41.43% 31.30% -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 31.51 114.66 85.22 56.50 28.51 114.75 85.43 -48.53%
EPS 6.70 26.80 20.10 13.40 6.90 23.20 16.90 -46.00%
DPS 5.00 20.00 15.00 10.00 5.00 20.00 15.00 -51.89%
NAPS 0.64 0.63 0.61 0.59 0.57 0.56 0.54 11.98%
Adjusted Per Share Value based on latest NOSH - 7,507,692
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 30.32 109.94 81.68 54.15 27.32 109.80 82.02 -48.46%
EPS 6.41 25.70 19.26 12.84 6.61 22.20 16.23 -46.13%
DPS 4.81 19.18 14.38 9.58 4.79 19.14 14.40 -51.82%
NAPS 0.6158 0.6041 0.5846 0.5655 0.5463 0.5359 0.5185 12.13%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 6.44 5.98 6.16 5.89 6.35 6.80 6.55 -
P/RPS 20.44 5.22 7.23 10.42 22.28 5.93 7.67 92.10%
P/EPS 96.69 22.31 30.65 43.96 92.03 29.31 38.76 83.83%
EY 1.03 4.48 3.26 2.28 1.09 3.41 2.58 -45.75%
DY 0.78 3.34 2.44 1.70 0.79 2.94 2.29 -51.19%
P/NAPS 10.06 9.49 10.10 9.98 11.14 12.14 12.13 -11.71%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 27/04/17 08/02/17 19/10/16 20/07/16 21/04/16 04/02/16 28/10/15 -
Price 6.44 6.29 6.01 6.12 5.95 6.15 6.65 -
P/RPS 20.44 5.49 7.05 10.83 20.87 5.36 7.78 90.28%
P/EPS 96.69 23.47 29.90 45.67 86.23 26.51 39.35 81.99%
EY 1.03 4.26 3.34 2.19 1.16 3.77 2.54 -45.18%
DY 0.78 3.18 2.50 1.63 0.84 3.25 2.26 -50.76%
P/NAPS 10.06 9.98 9.85 10.37 10.44 10.98 12.31 -12.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment